EMA SAWP meeting

So, this is it.
The meeting took and/or is taking place.

What is the outcome? How large is going to be the proposed clinical trial?
How long will it take?

Is possible to combine the new required European clinical trial with a combined USA FDA clinical trial?
Should be considered!

To have a new fresh start, if this is the case, can we have a US stock listing on the NASDAQ (with Treasury shares to be issued by the company on a ADR basis in the US) and have the market finance both clinical trials? We are in a Phase 2 stage in the USA. We could have a major marketing event and being listed in the US biotech magazines and would have the US speculative investors able to invest in Tissue Therapies.

This would become a US and European event.

Price with a potential demand and a proposed US listing would go up substantially and could reach the estimated US1.
Actually to be listed in the US in the NASDAQ you need to have a price listing above USD 1.

Let's have a thought, but please, let's start to be more market oriented than just researcher oriented. We have to be the next "Wolf of Wall Street".
Anything can be sold, just you need to have the proper person at the proper place and at the proper time and with the proper price able to sell OUR product.